01:34 AM EDT, 10/19/2026 (MT Newswires) -- DKSH (DKSH.SW) agreed to buy Dubai-based healthcare commercialization platform NewBridge Pharmaceuticals at an enterprise value of $390 million, according to a Monday release. The Swiss distribution company said the acquisition will pave the way for setting up a healthcare platform in the Middle East, considering NewBridge's existing operations in the Middle East and North Africa region. Completion of the acquisition is expected by the end of the first quarter of 2027, subject to regulatory approvals, among other closing conditions.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.